Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 25, 2014 16:30 ET | Source: Kite Pharma, Inc.

Kite Pharma Announces Patients With Aggressive Non-Hodgkin's Lymphoma Experience Positive Results After Receiving Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells at the National Cancer Institute (NCI)

Phase 1-2a Clinical Trial Highlights: 12 of 13 Total Evaluable Patients with Advanced B Cell Malignancies Had Complete Remissions (8 Patients) or Partial Remissions (4 Patients) Resulting in a...
August 14, 2014 17:40 ET | Source: Kite Pharma, Inc.

Kite Pharma Reports Second Quarter 2014 Results

Successfully Completed Initial Public Offering, Raised Net Proceeds of $134.1 Million Kite Advancing Clinical Development Pipeline of Its Proprietary eACT™-Based Product Candidates SANTA...
June 23, 2014 07:30 ET | Source: Kite Pharma, Inc.

Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

SANTA MONICA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
June 20, 2014 06:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Announces Pricing of Initial Public Offering

SANTA MONICA, Calif., June 20, 2014 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq: KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...